+987.9%
MRNA vs BP
+35.3%
+952.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -4.2% | +17.3% | +11.7% |
| 7D | +20.6% | -8.4% | +29.0% | +17.5% |
| 30D | +27.1% | +2.2% | +24.9% | +28.1% |
| 3M | +353.4% | +8.8% | +344.6% | +364.5% |
| 6M | +446.3% | -0.5% | +446.8% | +467.1% |
| YTD | +776.2% | +36.2% | +740.0% | +769.9% |
| 1Y | +987.9% | +36.6% | +951.4% | +886.3% |
| All | +987.9% | +35.3% | +952.7% | +886.3% |
Cumulative growth
Daily Returns
Daily percentage return beside BP.
Daily Out/Under-Performance
Portfolio return minus BP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling